These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24934184)

  • 1. Drug repurposing based on drug-drug interaction.
    Zhou B; Wang R; Wu P; Kong DX
    Chem Biol Drug Des; 2015 Feb; 85(2):137-44. PubMed ID: 24934184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.
    Tan F; Yang R; Xu X; Chen X; Wang Y; Ma H; Liu X; Wu X; Chen Y; Liu L; Jia X
    Mol Biosyst; 2014 May; 10(5):1126-38. PubMed ID: 24603772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug repurposing with network reinforcement.
    Nam Y; Kim M; Chang HS; Shin H
    BMC Bioinformatics; 2019 Jul; 20(Suppl 13):383. PubMed ID: 31337333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GES polypharmacology fingerprints: a novel approach for drug repositioning.
    Pérez-Nueno VI; Karaboga AS; Souchet M; Ritchie DW
    J Chem Inf Model; 2014 Mar; 54(3):720-34. PubMed ID: 24494653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Drug Repurposing Method Based on Drug-Drug Interaction Networks and Using Energy Model Layouts.
    Udrescu M; Udrescu L
    Methods Mol Biol; 2019; 1903():185-201. PubMed ID: 30547443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data.
    Iwata H; Sawada R; Mizutani S; Yamanishi Y
    J Chem Inf Model; 2015 Feb; 55(2):446-59. PubMed ID: 25602292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REPRODUCIBLE DRUG REPURPOSING: WHEN SIMILARITY DOES NOT SUFFICE.
    Guney E
    Pac Symp Biocomput; 2017; 22():132-143. PubMed ID: 27896969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case.
    Huang LC; Soysal E; Zheng W; Zhao Z; Xu H; Sun J
    BMC Syst Biol; 2015; 9 Suppl 4(Suppl 4):S2. PubMed ID: 26100720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of drug gene associations via ontological profile similarity with application to drug repositioning.
    Kissa M; Tsatsaronis G; Schroeder M
    Methods; 2015 Mar; 74():71-82. PubMed ID: 25498216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting drug-target interaction for new drugs using enhanced similarity measures and super-target clustering.
    Shi JY; Yiu SM; Li Y; Leung HC; Chin FY
    Methods; 2015 Jul; 83():98-104. PubMed ID: 25957673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tripartite Network-Based Repurposing Method Using Deep Learning to Compute Similarities for Drug-Target Prediction.
    Zong N; Wong RSN; Ngo V
    Methods Mol Biol; 2019; 1903():317-328. PubMed ID: 30547451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identify drug repurposing candidates by mining the protein data bank.
    Moriaud F; Richard SB; Adcock SA; Chanas-Martin L; Surgand JS; Ben Jelloul M; Delfaud F
    Brief Bioinform; 2011 Jul; 12(4):336-40. PubMed ID: 21768131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Computational Bipartite Graph-Based Drug Repurposing Method.
    Zheng S; Ma H; Wang J; Li J
    Methods Mol Biol; 2019; 1903():115-127. PubMed ID: 30547439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a tripartite network for the prediction of drug targets.
    Kunimoto R; Bajorath J
    J Comput Aided Mol Des; 2018 Feb; 32(2):321-330. PubMed ID: 29340865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
    Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
    Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug repurposing and adverse event prediction using high-throughput literature analysis.
    Deftereos SN; Andronis C; Friedla EJ; Persidis A; Persidis A
    Wiley Interdiscip Rev Syst Biol Med; 2011; 3(3):323-34. PubMed ID: 21416632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating Clinical Phenotype and Gene Expression Data to Prioritize Novel Drug Uses.
    Paik H; Chen B; Sirota M; Hadley D; Butte AJ
    CPT Pharmacometrics Syst Pharmacol; 2016 Nov; 5(11):599-607. PubMed ID: 27860440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical genetics-based drug repurposing for Alzheimer's disease.
    Zhang XZ; Quan Y; Tang GY
    Brain Res Bull; 2015 Jan; 110():26-9. PubMed ID: 25446738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathway analysis of GWAS loci identifies novel drug targets and repurposing opportunities.
    Jhamb D; Magid-Slav M; Hurle MR; Agarwal P
    Drug Discov Today; 2019 Jun; 24(6):1232-1236. PubMed ID: 30935985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-tiered unsupervised clustering approach for drug repositioning through heterogeneous data integration.
    Hameed PN; Verspoor K; Kusljic S; Halgamuge S
    BMC Bioinformatics; 2018 Apr; 19(1):129. PubMed ID: 29642848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.